Niramai and breast cancer detection


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
Will Niramai be able to reduce breast cancer deaths worldwide with its innovative AI-based solution? Will Niramai be able to reduce breast cancer deaths worldwide with its innovative AI-based solution?

Do you know breast cancer is the main cause of death from cancer in women?

WHO predicts that 1 in every 12 women are at the risk of developing breast cancer. Breast cancer has also been the biggest cause of cancer deaths in Indian women. An estimated 1.79 lakh women suffer from it. In 2013, Geetha Manjunath was working in an MNC which used artificial intelligence and analytics in the healthcare sector. There she learned how thermal imaging could be used for breast cancer detection.

Three years later and she went into talks with Xerox to use their technology to kick off her own venture. She was successful and then in 2017, she started Niramai. Niramai created a cancer screening tool that is low-cost and portable. The device works on women of all ages and is radiation-free, no-touch required and painless. It works on women of all ages. 

Their solution is already being used in Apollo Clinics, HCG Hospital and HealthSpring Diagnostics. Their tool, Thermalytix™, has even received CE mark approval, enabling it to enter the European Economic Area. Thermalytix™ uses AI, ML and big data analytics to detect the anomaly. They are also looking to enter other important markets like Africa and Asia. They have been in talks to collaborate with radiologists from the National Health Service (NHS).

To date, they have raised $7 million from multiple investors like Pi Ventures, BEENEXT, Dream Incubator and Axilor Ventures. In 2017, they received $50,000 from Google Launchpad Accelerator. Niramai has received numerous awards like Frost and Sullivan Award and the Gold prize in Hack Osaka. They have also been granted 10 patents from the USA, 3 from India, and more from both China and Singapore. Will Niramai be able to reduce breast cancer deaths worldwide with its innovative AI-based solution?

Tags : #Niramai #GeethaManjunath #breastcancer #breastcancerdetection #cancer #cancerdetection #Google #NHS #FrostandSullivan #AI #AIhealthcare #MediSpeak #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026